Factors associated with maternal consent for use of residual newborn bloodspots in the National Birth Defects Prevention Study-Reference-Cited by-同舟云学术

Factors associated with maternal consent for use of residual newborn bloodspots in the National Birth Defects Prevention Study

Published:2022-02-23 Issue:7 Volume:114 Page:238-248
ISSN:2472-1727
Container-title:Birth Defects Research
language:en
Short-container-title:Birth Defects Research

Author:

Wong Eugene C.¹^ORCID,Fisher Sarah C.²^ORCID,Feldkamp Marcia L.³^ORCID,Romitti Paul A.⁴^ORCID,Nestoridi Eirini⁵,Desrosiers Tania A.¹,Wong Eugene C.,Desrosiers Tania A.,Wong Eugene C.,Desrosiers Tania A.,Wong Eugene C.,Desrosiers Tania A.,Wong Eugene C.,Fisher Sarah C.,Feldkamp Marcia L.,Romitti Paul A.,Nestoridi Eirini,Desrosiers Tania A.,

Affiliation:

1. Department of Epidemiology Gillings School of Global Public Health, University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

2. Birth Defects Registry New York State Department of Health Albany New York USA

3. Division of Medical Genetics, Department of Pediatrics University of Utah School of Medicine Salt Lake City Utah USA

4. College of Public Health The University of Iowa Iowa City Iowa USA

5. Massachusetts Center for Birth Defects Research and Prevention Massachusetts Department of Public Health Boston Massachusetts USA

Funder

National Institute of Child Health and Human Development

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Developmental Biology,Toxicology,Embryology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdr2.1991

Reference34 articles.

1. Racial Differences in the Use of BRCA1/2 Testing Among Women With a Family History of Breast or Ovarian Cancer

2. Retention and Research Use of Residual Newborn Screening Bloodspots

3. Public Attitudes Regarding the Use of Residual Newborn Screening Specimens for Research

4. Update on overall prevalence of major birth defects—Atlanta, Georgia, 1978–2005;Centers for Disease Control and Prevention (CDC);Morbidity and Mortality Weekly Report,2008

5. Racial and Ethnic Disparity in Participation in DNA Collection at the Atlanta Site of the National Birth Defects Prevention Study